Selank vs Semax: Which Nootropic Peptide Is Right for Your Cognitive Goals?

If you're exploring nootropic peptides for cognitive enhancement or neuroprotection, two names inevitably dominate the conversation: Selank and Semax. Both developed at the Institute of Molecular Genetics (Russian Academy of Sciences), both administered intranasally, and both backed by clinical evidence from Russian research — yet these compounds deliver distinctly different cognitive profiles.

Choosing between them — or deciding to use both — requires understanding their unique mechanisms, evidence bases, and clinical applications. This comprehensive comparison breaks down everything you need to know.

---

Quick Comparison Summary

Feature	Selank	Semax
Primary action	Anxiolytic + nootropic	Neuroprotective + nootropic
Best for	Anxiety, stress, mood	Stroke recovery, neuroprotection, focus
Key mechanism	GABA/enkephalin modulation	BDNF upregulation
Anxiolytic effect	Strong	Mild-moderate
Neuroprotective effect	Moderate	Strong
Cognitive enhancement	Moderate (attention, memory)	Strong (memory, processing speed)
Regulatory approval	Russia (anxiety disorders)	Russia (stroke, cognitive disorders, optic nerve)
Administered	Intranasal	Intranasal
Side effects	Minimal	Minimal

---

Origins and Development

Both compounds trace their lineage to the work of Russian peptide neuroscientists, but they derive from entirely different parent molecules:

Selank: From Tuftsin to Heptapeptide

Selank is a synthetic analogue of tuftsin (Thr-Lys-Pro-Arg), an endogenous immunomodulatory tetrapeptide involved in macrophage activation and immune regulation. Researchers discovered that tuftsin fragments possessed unexpected central nervous system activity — particularly anxiolytic and nootropic effects. Selank was developed by extending and modifying the tuftsin sequence (Thr-Lys-Pro-Arg-Pro-Gly-Pro) to optimize CNS penetration and receptor binding.

Semax: From ACTH to Neuroprotection

Semax derives from the ACTH(4-10) fragment of adrenocorticotropic hormone. While ACTH itself stimulates cortisol release through the HPA axis, the ACTH(4-10) fragment (Met-Glu-His-Phe-Pro-Gly-Pro) retains neurotrophic and neuroprotective properties without hormonal corticotropic activity. This dissociation was the key insight enabling Semax's development as a pure CNS-active agent.

---

Mechanism of Action: A Deep Dive

Selank's Mechanisms

1. GABAergic Modulation Selank enhances GABAergic transmission through indirect mechanisms, increasing inhibitory tone in anxiety-related neural circuits (amygdala, prefrontal cortex, hippocampus). Unlike benzodiazepines, Selank does not directly bind GABA-A receptors, instead modulating GABA synthesis, release, and receptor sensitivity.

2. Enkephalinase Inhibition By inhibiting enzymes that degrade endogenous enkephalins, Selank prolongs the activity of natural mood-regulating peptides. This mechanism contributes to both its anxiolytic and mood-stabilizing properties.

3. Serotonin and Dopamine Modulation Selank normalizes monoamine turnover in key brain regions, with particular effects on serotonergic activity in the dorsal raphe and dopaminergic function in the prefrontal cortex.

4. BDNF Modulation (Moderate) Selank modestly increases BDNF expression, contributing to its nootropic effects, though less dramatically than Semax.

Semax's Mechanisms

1. Robust BDNF Upregulation Semax's primary mechanism involves potent induction of BDNF expression — approximately 1.5–2.0 fold increases in BDNF mRNA in hippocampal and cortical tissue. This drives the compound's neuroprotective, neurogenic, and pro-cognitive effects.

2. TrkB Receptor Signaling BDNF released by Semax activates the TrkB receptor, engaging MAPK/ERK (cell survival), PI3K/Akt (anti-apoptotic), and PLCγ (synaptic plasticity) pathways.

3. Serotonergic and Dopaminergic Enhancement Semax increases serotonin and dopamine turnover in prefrontal and hippocampal regions, supporting attention, motivation, and cognitive processing speed.

4. Gene Expression Modulation Semax influences 50+ genes involved in neurotrophin signaling, inflammation, and oxidative stress response.

Mechanistic Summary

Pathway	Selank	Semax
GABAergic modulation	Primary	Minor
Enkephalin modulation	Primary	Not significant
BDNF upregulation	Moderate	Primary
TrkB signaling	Minor	Primary
Serotonergic modulation	Moderate	Moderate-strong
Dopaminergic modulation	Mild	Moderate
Anti-inflammatory	Moderate	Strong
Gene expression breadth	~30 genes	~50+ genes

---

Clinical Evidence Comparison

Approved Indications (Russia)

Compound	Approved For	Year
Selank	Anxiety disorders, neurasthenia	2009
Semax	Stroke, cognitive disorders, optic nerve atrophy	2011

Head-to-Head Performance by Use Case

Anxiety Management:

• Selank wins. Direct GABAergic and enkephalinergic activity produces superior anxiolytic effects. Clinical trials demonstrate HAM-A score reductions of 62% — comparable to benzodiazepines without sedation or dependence.
• Semax has mild anxiolytic properties, likely secondary to its BDNF and monoamine effects, but is not primarily indicated for anxiety.

Post-Stroke Recovery:

• Semax wins. Multiple controlled trials demonstrate 20–35% greater neurological improvement vs. standard care. Selank has no comparable stroke data.

Cognitive Enhancement (Healthy Individuals):

• Semax likely superior for raw cognitive performance (memory consolidation, processing speed, working memory) due to robust BDNF induction.
• Selank may be preferable for cognitive performance under stress or anxiety, as it removes the cognitive interference of anxious ideation.

Neuroprotection:

• Semax wins decisively. Stronger evidence base, broader gene expression effects, and direct BDNF/TrkB-mediated neuroprotection.

Stress Resilience:

• Selank wins. HPA axis normalization and enkephalin extension provide superior stress adaptation without sedation.

Sleep Quality:

• Neither is a primary sleep aid. Selank may indirectly improve sleep through anxiety reduction. Consider DSIP for dedicated sleep enhancement.

---

Dosing Comparison

Parameter	Selank	Semax
Route	Intranasal	Intranasal
Standard dose	150–600 μg	200–600 μg
Enhanced variant dose	100–300 μg (N-Acetyl)	100–300 μg (N-Acetyl Amidate)
Frequency	2–3× daily	2–4× daily
Cycle length	10–14 days	10–14 days (acute), 21–30 days (chronic)
Cycle break	7–14 days	7–14 days
Onset	10–20 minutes	15–30 minutes
Duration of effects	4–6 hours	4–6 hours

---

Stacking Selank and Semax

For users seeking comprehensive cognitive optimization, combining Selank and Semax is a logical strategy — and one with established precedent in Russian clinical practice.

Rationale for Combination

The two compounds address complementary pathways:

• Selank → Reduces anxiety, enhances stress resilience, modulates mood
• Semax → Drives neuroprotection, enhances raw cognitive power, promotes neuroplasticity

Together, they create a "calm focus" profile that neither achieves alone.

Combination Protocol

Parameter	Recommendation
Selank dose	150–300 μg, intranasal, 2× daily
Semax dose	200–400 μg, intranasal, 2× daily
Administration	Simultaneous or staggered by 30 minutes
Timing	Morning + early afternoon (avoid evening dosing)
Cycle	14 days on, 14 days off
Priority if budget-constrained	Choose Semax (broader mechanisms)

When NOT to Stack

• If you have no anxiety component (Selank may be unnecessary)
• First-time users (start with one, assess tolerance, then add the second)
• If you're sensitive to serotonergic agents (combined monoamine effects)

---

Cost Considerations

Factor	Selank	Semax
Typical vial cost	$30–60 (5 mg)	$35–70 (5 mg)
Monthly cost (standard dosing)	$60–120	$70–140
Enhanced variants	Slightly higher	Slightly higher
Combination monthly cost	$130–260 (both)	—

Prices reflect typical US research peptide supplier ranges as of March 2026.

---

Decision Framework: Which Should You Choose?

Choose Selank if your primary goals are:

• ✅ Anxiety reduction without sedation
• ✅ Stress resilience and emotional regulation
• ✅ Mild cognitive enhancement with mood improvement
• ✅ Avoiding benzodiazepine-like side effects
• ✅ Neurasthenia or burnout recovery

Choose Semax if your primary goals are:

• ✅ Neuroprotection (stroke recovery, TBI, neurodegeneration)
• ✅ Maximum cognitive enhancement (memory, processing speed)
• ✅ BDNF-driven neuroplasticity and neurogenesis
• ✅ Post-concussion or brain injury recovery
• ✅ Long-term brain health optimization

Choose both if:

• ✅ You want comprehensive nootropic coverage
• ✅ You have anxiety AND cognitive performance goals
• ✅ Budget allows ($130–260/month)
• ✅ You've used each individually and tolerated well

---

Conclusion

Selank and Semax are not competitors — they're complementary tools optimized for different aspects of brain health. Selank excels in the anxiety-mood-stress axis through GABAergic and enkephalinergic mechanisms, while Semax dominates the neuroprotection-neuroplasticity-cognition axis through BDNF-driven pathways.

For most users, the choice comes down to primary concerns: anxiety → Selank, cognitive enhancement/neuroprotection → Semax, both → combine them. Whichever you choose, ensure proper sourcing, follow established dosing protocols, and consult with a knowledgeable healthcare provider.

---

Disclaimer

This article is for educational and informational purposes only and does not constitute medical advice. Both Selank and Semax are not FDA-approved in the United States and are classified as research compounds in Western markets. The comparison presented reflects available Russian clinical literature and preclinical research as of March 2026. Always consult a qualified healthcare professional before starting any peptide therapy.